Recommended Dosage of Toradol (Ketorolac)
The recommended dosage of Toradol (ketorolac) for adults is 10-30mg IV/IM for initial dosing, followed by oral dosing of 10mg every 4-6 hours as needed, not exceeding 40mg per day orally or 120mg per day total, with treatment duration limited to a maximum of 5 days. 1, 2
Dosage Guidelines by Route of Administration
Intravenous/Intramuscular Dosing
Standard adult dosing (age 17-64):
- Initial dose: 30mg IV or 60mg IM
- Subsequent doses: 15-30mg IV/IM every 6 hours
- Maximum daily dose: 120mg 1
High-risk populations (age ≥65, renal impairment, or weight <50kg):
Oral Dosing (Only as continuation therapy after IV/IM dosing)
Standard adult dosing (age 17-64):
- Initial oral dose: 20mg once
- Subsequent doses: 10mg every 4-6 hours as needed
- Maximum daily oral dose: 40mg 2
High-risk populations (age ≥65, renal impairment, or weight <50kg):
- Initial oral dose: 10mg once
- Subsequent doses: 10mg every 4-6 hours as needed
- Maximum daily oral dose: 40mg 2
Important Clinical Considerations
Duration of Treatment
- Combined duration of IV/IM and oral ketorolac should not exceed 5 days 1, 2, 3
- Prolonged use significantly increases risk of serious adverse events, particularly in elderly patients 4
Analgesic Ceiling Effect
- Research shows no additional analgesic benefit from doses exceeding 10mg IV 5
- Using the lowest effective dose (10mg IV) provides effective pain relief with potentially fewer adverse effects 5
Contraindications
Ketorolac is contraindicated in patients with:
- History of or current risk of gastrointestinal bleeding
- Risk of renal failure
- Compromised hemostasis
- Hypersensitivity to aspirin or other NSAIDs
- Pregnancy
- Cerebrovascular hemorrhage
- Aspirin/NSAID-induced asthma 1
Monitoring Requirements
- Baseline assessment recommended for:
- Blood pressure
- BUN and creatinine
- Liver function tests
- CBC and fecal occult blood 1
- Discontinue immediately if:
- Renal function tests double
- Hypertension develops or worsens
- Liver function studies increase beyond normal limits 1
Special Populations and Considerations
Perioperative Use
- For short-term perioperative therapy: 0.5-1mg/kg IV (up to 30mg) for a single intraoperative dose, or 0.15-0.2mg/kg (max 10mg) every 6 hours 1
- Effective for postoperative pain management with potential opioid-sparing effects of 25-50% 4, 6
Cancer Pain Management
- Can be administered via continuous subcutaneous infusion for cancer-related pain
- Particularly effective for bone metastasis-related pain 7
- May be mixed with opioids in syringe drivers for improved pain control 7
Emergency Department Use
- 10mg IV provides similar analgesic efficacy to higher doses (15mg and 30mg) for acute pain in the emergency department 5
- Effective for renal colic, migraine headache, musculoskeletal pain, and sickle cell crisis 4
Practical Application
- Always use the lowest effective dose for the shortest duration
- Oral formulation should not be given as an initial dose; only use as continuation therapy after IV/IM administration
- Do not shorten the dosing interval of 4-6 hours
- Avoid concurrent use with other NSAIDs to prevent increased risk of adverse effects 1, 2